Skip to content

Smoking cessation with smartphone application: real world trial

Smoking cessation with smartphone application: real world trial - START

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045678
Enrollment
560
Registered
2021-10-31
Start date
2021-09-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine dependence

Interventions

None listed

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with "nicotine dependence" who are eligible for insurance benefits among patients who visit outpatient clinics for smoking cessation will be covered. In other words, patients must: 1) intend to quit smoking immediately; 2) have a score of 5 or higher on the Tobacco Dependence Screener (hereinafter referred to as TDS), a screening test for nicotine dependence; 3) have a smoking history of 10 Pack-years, if the patient is 35 years old or older; 4) The patient must have given written consent to receive smoking cessation treatment. 2. Age: 20 years or older at the time of obtaining consent 3. Patients who can use a smartphone (OS: Android 5.0 or newer, iPhone 8.0 or newer) (criteria for the CureApp SC group only)

Exclusion criteria

Exclusion criteria: Patients who do not consent to this study

Design outcomes

Primary

MeasureTime frame
Continuous abstinence rate (CAR) from weeks 9 to 24

Secondary

MeasureTime frame
CAR from weeks 9 to 52 Seven-day point prevalence abstinence rate from weeks 4, 8, 12, 24 and 52 Changes of scores of KTSND; Kano Test for Social Nicotine Dependence, from first visit to weeks 12 KTSND scores at weeks 12 Usage rate of the CureApp SC and its functions: digital diary, a personalized chatbot and smoking cessation educational programs Weight change

Countries

Japan

Contacts

Public ContactMayuko Watase

Keio University School of Medicine Department of Internal Medicine, Division of Pulmonary Medicine

mayukowatase@keio.jp03-5363-3793

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026